The agenda features a mix of clinical updates and lively debates on provocative scientific topics impacting the field, including emerging concepts and therapies in multiple myeloma, lymphoma, acute and chronic lymphocytic leukemia, myeloid malignancies, and much more.



Chronic Lymphocytic Leukemia
Acute Lymphoblastic Leukemia
Acute Myeloid Leukemia/ Myelodysplastic Syndrome
Multiple Myeloma

Engaging Debates

CNS Prophylaxis in Aggressive Lymphoma - Aggressive/ Futile
Should MRD+ Patients with AML Proceed with HSCT? Yes / No
Will ASCT Continue to Be the Standard of Care in Frontline Therapy? Yes / No